For over 20 years, bioStrategies has developed commercial insight to inform evidence-based impactful commercialization strategies for pharmaceuticals, vaccines, medical devices, and diagnostics. Our approach combines detailed market research and proprietary analytical tools with technical and strategic understanding to deliver timely, actionable recommendations. We specialize in evaluation of complex commercialization issues in the U.S. and Europe as well as other global healthcare markets
View Top Employees from bioStrategies GroupWebsite | http://www.biostrategies.com. |
Revenue | $2 million |
Funding | $350000 |
Employees | 19 (19 on RocketReach) |
Founded | 1995 |
Address | 29 North Wacker Drive Suite 1000, Chicago, Illinois 60616, US |
Phone | (312) 482-8292 |
Technologies | |
Industry | Business Consulting and Services, Business Services General, Business Services |
Web Rank | 29 Million |
Keywords | Biostrategies |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54191 Companies, NAICS Code 5419 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541910 Companies |
Looking for a particular bioStrategies Group employee's phone or email?
The bioStrategies Group annual revenue was $2 million in 2024.
Mike Kaestle is the President of bioStrategies Group.
19 people are employed at bioStrategies Group.
bioStrategies Group is based in Chicago, Illinois.
The NAICS codes for bioStrategies Group are [54191, 5419, 54, 541, 541910].
The SIC codes for bioStrategies Group are [873, 87].